1. Home
  2. EZPW vs NVCR Comparison

EZPW vs NVCR Comparison

Compare EZPW & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo EZCORP Inc. Non Voting

EZPW

EZCORP Inc. Non Voting

HOLD

Current Price

$30.17

Market Cap

2.0B

ML Signal

HOLD

Logo NovoCure Limited

NVCR

NovoCure Limited

HOLD

Current Price

$16.58

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EZPW
NVCR
Founded
1989
2000
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Other Specialty Stores
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
2.0B
IPO Year
1996
2015

Fundamental Metrics

Financial Performance
Metric
EZPW
NVCR
Price
$30.17
$16.58
Analyst Decision
Buy
Buy
Analyst Count
3
6
Target Price
$30.67
$28.08
AVG Volume (30 Days)
781.3K
927.8K
Earning Date
05-12-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
29.09
21.79
EPS
1.65
N/A
Revenue
$747,954,000.00
$655,353,000.00
Revenue This Year
$25.40
$7.72
Revenue Next Year
$11.33
$6.74
P/E Ratio
$18.25
N/A
Revenue Growth
2.39
8.28
52 Week Low
$16.50
$9.82
52 Week High
$37.13
$21.45

Technical Indicators

Market Signals
Indicator
EZPW
NVCR
Relative Strength Index (RSI) 42.04 47.99
Support Level $28.10 $16.33
Resistance Level $31.80 $18.43
Average True Range (ATR) 1.09 0.75
MACD -0.35 -0.05
Stochastic Oscillator 15.51 40.97

Price Performance

Historical Comparison
EZPW
NVCR

About EZPW EZCORP Inc. Non Voting

EZCORP Inc is a United States-based company engaged in offering pawn loans in the United States and Mexico. It also offers short-term unsecured loans and other consumer financial products, and buys and sells second-hand goods. The operating segments of the company are U.S. Pawn, Latin America Pawn, and Other Investments. The U.S. Pawn segment includes all pawn activities in the United States. The Latin America Pawn segment includes all pawn activities in Mexico and other parts of Latin America. The company generates revenue from merchandise sales, jewelry scrapping sales, and pawn service charges, of which key revenue is derived from the merchandise sales, which are mainly collateral forfeited from pawn lending operations and used merchandise purchased from the customers.

About NVCR NovoCure Limited

NovoCure Ltd is an oncology company with a proprietary platform technology in the United States. Its business involves the development, manufacture, and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis, and other products and technologies for the treatment of Glioblastoma, Non-small cell lung cancer, and Pancreatic cancer. Geographically, the company derives the majority of its revenue from the United States and the rest from Germany, Japan, and other markets.

Share on Social Networks: